INVESTORS
Investing in the future of accessible care.
We’re scaling an AI-powered platform that lowers the cost of musculoskeletal care while improving outcomes — addressing one of healthcare’s largest and most underserved cost centers.
TRACTION · LIVE
4.2×YoY GROWTH
BY THE NUMBERS
Momentum that compounds.
global MSK market
$
500
B
YoY revenue growth
0
x
net revenue retention
0
%
lower cost of care delivered
0
%
THE OPPORTUNITY
A large, inefficient market ready for AI.
Musculoskeletal conditions are the #1 driver of healthcare spend and lost productivity, yet care remains fragmented and access uneven. Our platform attacks the cost curve at its source.
TRAJECTORY
Milestones & roadmap.
From first clinical validation to multi-payer deployment, our path compounds clinical evidence with commercial scale.
2023
Clinical validation
ROM + AI intake validated with leading orthopedic specialists.
2024
First payer partnerships
Launched with regional health plans; 3× at-risk detection proven.
2025
Platform scale
Jessica end-to-end documentation + multi-condition expansion.
2026
National expansion
Enterprise payer + employer rollout across new markets.
BUSINESS MODEL
Aligned to outcomes, built to scale.
Recurring, value-aligned revenue that compounds as we expand conditions and contracts.
Per-member-per-month
Predictable subscription revenue across covered populations, with expansion as engagement grows.
Value-based outcomes
Shared-savings arrangements tied to surgeries avoided and total-cost-of-care reduction.
Enterprise platform
Provider and employer licensing of Jessica, ROM, and documentation as an integrated suite.
net revenue retention
0
%
LTV / CAC
0
x
gross margin
0
%
CAC payback
<
0
mo
WHY WE WIN
A widening moat across data, model, and care.
Each patient interaction sharpens our motion-intelligence models and documentation engine — a compounding advantage competitors can’t shortcut.
- ✓Proprietary motion datasetCamera-based ROM at scale — no wearables, fully remote.
- ✓End-to-end documentationFrom intake to SOAP note to summary — the full clinical loop.
- ✓Human + AI care modelClinician trust plus AI scale — defensible on both axes.
DATA FLYWHEEL
+2.1M sessions
Model v8
Accuracy ↑
SERIES B · USE OF FUNDS
Capital deployed where it compounds.
Our raise accelerates clinical evidence, payer expansion, and the AI platform that drives our cost advantage.
AI platform & R&D40%
Payer & employer GTM32%
Clinical evidence & trials18%
Operations & compliance10%